Palatin Technologies Inc PTN:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
1.84quote price arrow down-0.03 (-1.60%)
Volume
2,755
Close
1.87UNCH (UNCH)
Volume
351,216
52 week range
1.43 - 5.65
Loading...
  • Open1.61
  • Day High1.92
  • Day Low1.61
  • Prev Close1.60
  • 52 Week High5.65
  • 52 Week High Date01/29/24
  • 52 Week Low1.43
  • 52 Week Low Date09/28/23

Key Stats

  • Market Cap30.176M
  • Shares Out16.14M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-53.02

KEY STATS

  • Open1.61
  • Day High1.92
  • Day Low1.61
  • Prev Close1.60
  • 52 Week High5.65
  • 52 Week High Date01/29/24
  • 52 Week Low1.43
  • 52 Week Low Date09/28/23
  • Market Cap30.176M
  • Shares Out16.14M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-53.02

RATIOS/PROFITABILITY

  • EPS (TTM)-2.48
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-1.28
  • EBITDA (TTM)-30.548M
  • ROE (TTM)-1,246.70%
  • Revenue (TTM)7.098M
  • Gross Margin (TTM)95.34%
  • Net Margin (TTM)-435.53%
  • Debt To Equity (MRQ)-0.88%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Palatin Technologies Inc

 

Profile

MORE
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with unmet medical need and commercial potential. Its new product development activities focus primarily on MC1r agonists, with potential to treat inflammatory and autoimmune diseases, such as dry eye...
John Prendergast
Independent Chairman of the Board
Carl Spana Ph.D.
President, Chief Executive Officer, Director
Stephen Wills CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Address
4B Cedar Brook Drive
Cranbury, NJ
08512
United States

Top Peers

SYMBOLLASTCHG%CHG
TCON
TRACON Pharmaceuticals Inc
0.4298UNCHUNCH
SPRB
Spruce Biosciences Inc
0.7859UNCHUNCH
TNXP
Tonix Pharmaceuticals Holding Corp
0.186UNCHUNCH
SYBX
Synlogic Inc
1.79UNCHUNCH
OCX
OncoCyte Corp
2.93UNCHUNCH